JAZZ Buybacks
21 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–21; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| Jazz Pharmaceuticals plc | 2025-12-31 | Reported repurchase cash | $0.00 |
| Jazz Pharmaceuticals plc | 2024-12-31 | Reported repurchase cash | $0.00 |
| Jazz Pharmaceuticals plc | 2023-12-31 | Reported repurchase cash | $99.8M |
| Jazz Pharmaceuticals plc | 2022-12-31 | Reported repurchase cash | $0.00 |
| Jazz Pharmaceuticals plc | 2021-12-31 | Reported repurchase cash | $0.00 |
| Jazz Pharmaceuticals plc | 2021-03-31 | Reported repurchase cash | $0.00 |
| Jazz Pharmaceuticals plc | 2020-12-31 | Reported repurchase cash | $0.00 |
| Jazz Pharmaceuticals plc | 2020-03-31 | Reported repurchase cash | $139.05M |
| Jazz Pharmaceuticals plc | 2019-12-31 | Reported repurchase cash | $110.34M |
| Jazz Pharmaceuticals plc | 2019-03-31 | Reported repurchase cash | $111.25M |
| Jazz Pharmaceuticals plc | 2018-12-31 | Reported repurchase cash | $446.66M |
| Jazz Pharmaceuticals plc | 2018-03-31 | Reported repurchase cash | $34.55M |
| Jazz Pharmaceuticals plc | 2017-12-31 | Reported repurchase cash | $42.37M |
| Jazz Pharmaceuticals plc | 2017-03-31 | Reported repurchase cash | $13.9M |
| Jazz Pharmaceuticals plc | 2016-12-31 | Reported repurchase cash | $18.48M |
| Jazz Pharmaceuticals plc | 2016-03-31 | Reported repurchase cash | $134.37M |
| Jazz Pharmaceuticals plc | 2015-12-31 | Reported repurchase cash | $40.25M |
| Jazz Pharmaceuticals plc | 2015-03-31 | Reported repurchase cash | $10.34M |
| Jazz Pharmaceuticals plc | 2014-12-31 | Reported repurchase cash | $12.24M |
| Jazz Pharmaceuticals plc | 2014-03-31 | Reported repurchase cash | $0.00 |
| Jazz Pharmaceuticals plc | 2013-12-31 | Reported repurchase cash | $34.09M |